BHVN Q1 2018 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$83M

Net Income

-$85M

EPS (Diluted)

$-2.32

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$82M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$126M

Total Liabilities

$18M

Stockholders' Equity

$108M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$83M	-$14M	-475.5%
Net Income	-$85M	-$19M	-355.7%